Table I. Patient demographics.
| Study group/age range | Diagnosis/stage of menstrual cycle | Lesion type (N) 1 |
|---|---|---|
| Control (N = 20) | Leiomyomas | |
| 24–48 years of age | Proliferative (N = 7) | |
| Proliferative (N = 7) | ||
| Endometrial polyps | ||
| Proliferative (N = 3) Secretory (N = 2) |
||
| Endometriosis (N = 79) | qRT-PCR studies (N = 55) | Lesion type (N = 79) |
| 21–45 years of age | ||
| Stage I/II endometriosis (N = 20 | ||
| Proliferative (N = 9) | P (10), O (2), F (1) | |
| Secretory (N = 11) | P (12), O (2), F (1), | |
| CDS (1) | ||
| Stage III/IV endometriosis (N = 35) | ||
| Proliferative (N = 11) | P (13), F (1) | |
| Secretory (N = 24) | P (25), O (7), F (2), | |
| CDS (2) | ||
| IHC studies (N = 28) | ||
| Stage I/II endometriosis | ||
| Proliferative (N = 3) | P (2), O (1) | |
| Secretory (N = 3) | P (2), O (1) | |
| Stage III/IV endometriosis | ||
| Proliferative (N = 13) | P (2), O (1) | |
| Secretory (N = 9) | P (6), O (3) |
1 N indicates the number of each lesion type within group. Abbreviations: P = peritoneal biopsy, O = ovarian endometrioma, F = fibrotic lesion, CDS = cul-de sac lesion.